Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,806 | -41,564 | -25,572 | -10,894 | -20,537 |
| Depreciation Amortization | -1,566 | -2,297 | -1,739 | -610 | -1,200 |
| Accounts receivable | -515 | -509 | -412 | -640 | N/A |
| Accounts payable and accrued liabilities | 2,017 | 2,888 | 3,062 | -615 | N/A |
| Other Working Capital | 1,873 | 3,191 | 2,474 | -3,863 | -4,305 |
| Other Operating Activity | 1,825 | -1,269 | -3,411 | -940 | -11,884 |
| Operating Cash Flow | $-59,172 | $-39,560 | $-25,598 | $-17,562 | $-37,926 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -58,974 | -101,067 | -102,802 | 13,852 | N/A |
| PPE Investments | -511 | -326 | N/A | N/A | -144 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -82,698 |
| Investing Cash Flow | $-59,485 | $-101,393 | $-102,802 | $13,852 | $-82,842 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 272,882 | 131 | 112 | 9,387 | N/A |
| Other Financing Activity | 146,028 | 148,131 | 149,791 | 0 | 129,550 |
| Financing Cash Flow | $418,910 | $148,262 | $149,903 | $9,387 | $129,550 |
| Beginning Cash Position | 25,833 | 25,833 | 25,833 | 25,833 | 17,051 |
| End Cash Position | 326,086 | 33,142 | 47,336 | 31,510 | 25,833 |
| Net Cash Flow | $300,253 | $7,309 | $21,503 | $5,677 | $8,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,172 | -39,560 | -25,598 | -17,562 | -37,926 |
| Capital Expenditure | -511 | -326 | N/A | N/A | N/A |
| Free Cash Flow | -59,683 | -39,886 | -25,598 | -17,562 | -37,926 |